Kaempferia galanga L. extract and its main component, ethyl p-methoxycinnamate, inhibit the proliferation of Ehrlich ascites tumor cells by suppressing TFAM expression

[1]  I. El-Garawani,et al.  Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice , 2022, Scientific Reports.

[2]  J. Levita,et al.  Anti-Inflammatory Activity and Wound Healing Effect of Kaempferia galanga L. Rhizome on the Chemical-Induced Oral Mucosal Ulcer in Wistar Rats , 2022, Journal of inflammation research.

[3]  Md. Chayan Ali,et al.  Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review , 2022, Heliyon.

[4]  U. Göransson,et al.  Kaempferia galanga L.: Progresses in Phytochemistry, Pharmacology, Toxicology and Ethnomedicinal Uses , 2021, Frontiers in Pharmacology.

[5]  Shiow-Yi Chen,et al.  Hesperidin and Chlorogenic Acid Synergistically Inhibit the Growth of Breast Cancer Cells via Estrogen Receptor/Mitochondrial Pathway , 2021, Life.

[6]  D. Chanda,et al.  Standardization of Kaempferia galanga L. rhizome and vasorelaxation effect of its key metabolite ethyl p-methoxycinnamate. , 2021, Journal of ethnopharmacology.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  V. Schirrmacher.  From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review) , 2018, International journal of oncology.

[9]  Weikang Guo,et al.  The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells , 2018, Cancer Cell International.

[10]  Herbert Waldmann,et al.  Bioactive Compound Collections: From Design to Target Identification , 2018 .

[11]  Tarek M. Mohamed,et al.  Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice. , 2018, Chemico-biological interactions.

[12]  Yibing Chen,et al.  Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer , 2018, Signal Transduction and Targeted Therapy.

[13]  B. Kaufman,et al.  The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms , 2018, FEBS letters.

[14]  Hongyu Liu,et al.  Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review). , 2018, Oncology reports.

[15]  Xiangrong Chen,et al.  KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM , 2018, Artificial cells, nanomedicine, and biotechnology.

[16]  Xu Cao,et al.  Mitochondrial transcription factor A protects human retinal endothelial cell injury induced by hypoxia , 2017 .

[17]  Hanif Ali,et al.  Antioxidant and antineoplastic activities of methanolic extract of Kaempferia galanga Linn. Rhizome against Ehrlich ascites carcinoma cells , 2017, Journal of King Saud University - Science.

[18]  N. Kassim,et al.  Antioxidant properties of ginger (Kaempferia angustifolia Rosc.) and its chemical markers , 2017 .

[19]  K. Na-Bangchang,et al.  Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract , 2017, BMC Complementary and Alternative Medicine.

[20]  M. Yarmo,et al.  Cytotoxicity Activity of Biotransformed Ethyl p-methoxycinnamate by Aspergillus niger , 2016 .

[21]  Feng Xu,et al.  microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer. , 2014, DNA and cell biology.

[22]  M. Asmawi,et al.  Ethyl-p-methoxycinnamate isolated from kaempferia galanga inhibits inflammation by suppressing interleukin-1, tumor necrosis factor-α, and angiogenesis by blocking endothelial functions , 2014, Clinics.

[23]  F. Buonaguro,et al.  CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity , 2014, BioMed research international.

[24]  Bulent Ozpolat,et al.  Nanotechnology in cancer therapy , 2013, Journal of drug targeting.

[25]  J. Skotheim,et al.  Control of cell cycle transcription during G1 and S phases , 2013, Nature Reviews Molecular Cell Biology.

[26]  M. Inagaki,et al.  Cell cycle progression by the repression of primary cilia formation in proliferating cells , 2013, Cellular and Molecular Life Sciences.

[27]  J. Yun,et al.  p21(WAF¹/C¹P¹) deficiency induces mitochondrial dysfunction in HCT116 colon cancer cells. , 2013, Biochemical and biophysical research communications.

[28]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[29]  Chin-Tarng Lin,et al.  Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy. , 2011, Oncology reports.

[30]  S. Hoffner,et al.  Ethyl p-methoxycinnamate isolated from a traditional anti-tuberculosis medicinal herb inhibits drug resistant strains of Mycobacterium tuberculosis in vitro. , 2011, Fitoterapia.

[31]  Bin Han,et al.  Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth. , 2011, Biochemical and biophysical research communications.

[32]  Xianghui Ma,et al.  Anticancer drug discovery in the future: an evolutionary perspective. , 2009, Drug discovery today.

[33]  N. Koitabashi,et al.  Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription. , 2009, Cardiovascular research.

[34]  Guang Yao,et al.  Sensing and Integration of Erk and PI3K Signals by Myc , 2008, PLoS Comput. Biol..

[35]  I. Matsui‐yuasa,et al.  Mechanism of growth inhibitory effect of cape aloe extract in ehrlich ascites tumor cells. , 2007, Journal of nutritional science and vitaminology.

[36]  G. Wilson,et al.  Human mitochondrial transcription factor A possesses multiple subcellular targeting signals , 2007, The FEBS journal.

[37]  C. Gustafsson,et al.  Mitochondrial transcription and its regulation in mammalian cells. , 2007, Trends in biochemical sciences.

[38]  N. Hamasaki,et al.  Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. , 2007, Mitochondrion.

[39]  D. Newman,et al.  Plants as a source of anti-cancer agents. , 2005, Journal of ethnopharmacology.

[40]  Kathryn A. O’Donnell,et al.  Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.

[41]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[42]  J. Diehl.  Cycling to Cancer with Cyclin D1 , 2002, Cancer biology & therapy.

[43]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[44]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[45]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.

[46]  S. Lippard,et al.  Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin , 1995, Nature.

[47]  J. Barrett,et al.  Cell cycle controls: potential targets for chemical carcinogens? , 1993, Environmental health perspectives.

[48]  D. A. Clayton,et al.  Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. , 1991, Science.

[49]  Ni Putu Ermi Hikmawanti,et al.  Chemical Component of Kencur (Kaemferia galanga L.) Ethanolic Extract Using Gas Chromatography-Mass Spectrometry , 2021, IOP Conference Series: Earth and Environmental Science.

[50]  W. Lestari,et al.  Anti-neoplastic potential of ethyl-p-methoxycinnamate of Kaempferia galanga on oral cancer cell lines , 2019, Materials Today: Proceedings.

[51]  M. Fukushima,et al.  Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis. , 2008, International journal of oncology.

[52]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[53]  K. Dux,et al.  Of ehrlich ascites carcinoma. , 1967 .